-
Abstract Number: PB0715
Safe and Effective Prophylaxis with Plasma-derived Factor X Concentrate in an Elderly Patient with Hereditary Factor X Deficiency
-
Abstract Number: PB1133
Safety and Effectiveness of an Institutional Recommendation on the Management of Cancer Associated Venous Thrombosis: Results of a Real World Study with One-year Follow-up
-
Abstract Number: PB0503
Safety and Efficacy of Concizumab Prophylaxis Following a Switch from rFVIIa on-demand Treatment: Sub-analysis Results from the Phase 2 Explorer4 Trial in Patients with Hemophilia A or B with Inhibitors
-
Abstract Number: PB0722
Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-marketing Observational Study
-
Abstract Number: PB1221
Safety and Efficacy of Low-Molecular Weight Heparin Regimes for Venous Thromboembolism Prophylaxis in Bariatric Surgery
-
Abstract Number: OC 76.4
Safety and Efficacy of the Direct Oral Anticoagulants in Cerebral Vein Thrombosis: A Systematic Review and Meta-analysis
-
Abstract Number: LPB0004
Safety and Efficacy of Using Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with Pre-obesity and Obesity
-
Abstract Number: OC 73.2
Safety and Efficiency of Diagnostic Strategies for Ruling out Pulmonary Embolism in Important Patient Subgroups: A Systematic Review and Individual-patient Data Meta-analysis
-
Abstract Number: LPB0002
Safety and Pharmacokinetics of Direct Oral Anticoagulants after Bariatric Surgery: A Systematic Review
-
Abstract Number: OC 06.3
Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Low Molecular Weight Heparin (LWMH) in Gastrointestinal and Genito-urinary Cancers
-
Abstract Number: LPB0114
Safety of FEIBA and Emicizumab (SAFE): Dose Escalation Study Evaluating the Safety of in vivo Administration of Activated Prothrombin Complex Concentrate in Hemophilia A Patients with Inhibitors on Emicizumab
-
Abstract Number: PB1247
Safety Profile of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism without a Recent History of Cancer
-
Abstract Number: PB1015
Salt Bridge Formation Between A1 Domain of von Willebrand Factor and Platelet Glycoprotein (GP) Ibα by Molecular Dynamics Simulations
-
Abstract Number: PO131
SARS-CoV 2 and Venous Thromboembolism: A Risk beyond Thromboprophylaxis
-
Abstract Number: PB0136
SARS-CoV-2 Derived Peptides Potentiate Pro-inflammatory and Pro-coagulant Responses to the TLR3 Ligand Poly(I:C) in Human Endothelial Cells and Mice
-
Abstract Number: OC 03.2
SARS-CoV-2 Infection of K18-hACE2 Transgenic Mice Induces an Early Hyperactive Phenotype in Circulating Platelets
-
Abstract Number: PB0157
SARS-CoV2 Spike Protein Can Activate Platelets through Integrin Alpha IIb Beta 3
-
Abstract Number: PO115
Seasonal Changes of Platelet Aggregation Indexes at the Patients with Stable Angina
-
Abstract Number: PB1138
Secondary Prophylaxis of Venous Thromboembolism with Direct Oral Anticoagulants in Patients with Major Congenital Thrombophilia vs Non-thrombofilic Patients
-
Abstract Number: PB0767
Selected Platelet Parameters in Patients with Rheumatoid Arthritis at Total Hip Arthroplasty
-
Abstract Number: PB0073
Selective Small Molecule Factor XIIa Inhibitor KV998083 Protects against FeCl3 Induced Arterial Thrombosis in Mice
-
Abstract Number: PO157
Self-Administration of Romiplostim in Patients with Chronic Immune Thrombocytopenia Compared with Administration by a Healthcare Provider: A Single Center Experience
-
Abstract Number: LPB0069
Self-Propelled Hemostatic Powder Safely Achieves and Maintains Hemostasis in a Live Porcine Model of Upper Gastrointestinal Bleeding
-
Abstract Number: PB1085
Self-report Instruments for Assessing Adherence to Oral Anticoagulation with Warfarin: A Systematic Review
-
Abstract Number: PB0048
Sensitivity Analysis of a Reduced Model of Thrombosis under Flow: Roles of Factor IX, Factor XI, and γ’-Fibrin
-
Abstract Number: PB0921
Sensitivity of ISTH Bleeding Assessment Tool, Bleeding Time and PFA-200 in the Diagnosis of von Willebrand Disease
-
Abstract Number: PO137
Sepsis-induced Disseminated Intravascular Coagulation Secondary to COVID-19 and Baricitinib Treatment
-
Abstract Number: PB0972
Serglycin, an Intragranular Proteoglycan with Many Effects on Platelet Function
-
Abstract Number: PB0211
Serum ACE2 Activity for the Assessment of Disease Prognosis in COVID-19
-
Abstract Number: PB0835
Serum Complement Levels in Immune Thrombocytopenia: Relation with Clinical Presentation and Treatment Response
-
Abstract Number: PB0091
Severe Coagulopathy Induced by Therapeutic Plasma Exchange – A Case Report
-
Abstract Number: PB0724
Severe Congenital Factor XIII-A Deficiency: A Clinical Case
-
Abstract Number: LPB0122
Severe FXI Deficiency a Pediatric Cohort
-
Abstract Number: PO150
Severe Hemophilia C in a 70-year-old Woman: A Clinical Case
-
Abstract Number: OC 54.2
Severe High Molecular Weight Kininogen (HK) Deficiency: Clinical Characteristics, and KNG1 Mutations in Reported and New Cases
-
Abstract Number: PB0234
Severe SARS-CoV-2 Infection is Associated with Impaired Fibrinolysis: A Single Center Study of the Viscoelastic Properties of Blood Clot
-
Abstract Number: PB0809
Severe Thrombosis Progression Despite Anticoagulation – Case Report of Antithrombin Deficiency
-
Abstract Number: PB0245
Sex Differences in Thromboinflammatory Biomarkers in Patients with COVID-19: Preliminary Findings from a Retrospective, Single Center Study
-
Abstract Number: PB0979
Sex Differences in Thrombosis through Platelet Nitric Oxide Production
-
Abstract Number: PB1289
Sex-specific Association of Endogenous PCSK9 with Memory Function in Elderly Subjects at High CV Risk
-
Abstract Number: OC 13.1
Shear-induced Platelet-GPIbα Shedding under Extracorporeal Membrane Oxygenation Promotes Thrombocytopenia Independently from von Willebrand Factor
-
Abstract Number: PB0033
Short Peptides in the Regulation Blood Cells Aggregation in Thrombogenesis
-
Abstract Number: PB1087
Should We Check the Anticoagulant Activity Of Edoxaban, at Least at the Beginning of the Treatment?
-
Abstract Number: OC 59.2
SIG-009: Novel Encapsulated Non-viral Cell-based Therapy for FVII Deficiency
-
Abstract Number: PB0224
Significance of D-Dimers in Patients with COVID-19 Having Venous Thromboembolism
-
Abstract Number: PB0020
Single Centre Retrospective Chart Review to Examine the Management of Timing of Anticoagulation and Outcomes in Patients with Cerebral Venous Sinus Thrombosis
-
Abstract Number: PB0396
Single-cell Level Quantification of Surface Proteins in Platelets and Platelet-derived EVs Using SC-ICP-MS
-
Abstract Number: PB0955
Single-cell RNA Sequencing Reveals Features of Hematopoietic Stem and Progenitor Cells in Immune Thrombocytopenia
-
Abstract Number: PB1012
Single-cell Transcriptomics of Young and Mature Thrombocytes in Zebrafish
-
Abstract Number: LPB0062
Smartphone-based Detection of Platelet Activation in Microfluidic Strips
-
Abstract Number: PB0517
Soccer Is Popular and Relatively Safe for Children and Young Adults with Hemophilia: Experiences from the Netherlands
-
Abstract Number: PB1208
Solitary versus Multiple Subsegmental Pulmonary Emboli: Clinical Characteristics and Outcomes
-
Abstract Number: PB0017
Soluble P-selectin is Associated with Increased Risk of Ischemic Stroke in Patients with Atrial Fibrillation on Hemodialysis: Results from the VIVALDI Study
-
Abstract Number: PB1022
Soluble Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 (sTLT-1) as a Biomarker for Stable Cardiovascular Diseases
-
Abstract Number: OC 16.3
Specialized SPARC-forming Regulatory T Cells Control Venous Blood Clot Degradation
-
Abstract Number: PB0779
Specificity and Sensitivity of Pediatric Bleeding Questionnaire (PBQ) in Identifying Patients Requiring further Laboratory Evaluation
-
Abstract Number: PB0475
Spectrum of F8/F9 Gene Mutations in the PedNet Cohort
-
Abstract Number: OC 21.3
Spectrum of Acquired Platelet Dysfunction with Eosinophilia (APDE) in Tertiary Care Centre in South India
-
Abstract Number: PB0516
Sports Injuries in Dutch People with Hemophilia: Results of a 12 Months’ Prospective Study
-
Abstract Number: PB0197
Stability of Oral Anticoagulant Treatment with Vitamin K Antagonists in COVID-19 Patients
-
Abstract Number: PO106
Stable Fibroatheromatic Plaque Regression Using High-dose Atorvastatin-loaded PESDA Microbubbles-mediated Extracorporeal Shock Wave Sonoporation Therapy
-
Abstract Number: PB0631
Standard Prophylactic Regimen Is Three Times and Twice a Week in Hemophilia A and B, Respectively. The Low Dose Tailoring Method of Prophylaxis Has Been Introduced for Patients with Hemophilia
-
Abstract Number: PB0371
Standardization and Automation of Lupus Anticoagulant Diagnosis Using a Complex Automated Algorithm
-
Abstract Number: PB1001
Standardization of Platelet-rich Plasma Preparation with Optimal Platelet Function for the Use in Veterinary Regenerative Medicine
-
Abstract Number: PB1282
Standardized Direct Oral Anticoagulants Prescription for the Treatment of Acute Deep Vein Thrombosis in the Emergency Department: A Quality Improvement Initiative
-
Abstract Number: PB1271
Statin Use and Recurrence of Venous Thromboembolic Event
-
Abstract Number: PB1148
Statins for Venous Event Reduction in Patients with Venous Thromboembolism: A Multicenter Randomized Controlled Pilot Trial with a Focus on Prevention of Post-thrombotic Syndrome
-
Abstract Number: PB1255
Statins for Venous Event Reduction in Patients with Venous Thromboembolism: A Randomized Controlled Pilot Trial Assessing Feasibility
-
Abstract Number: PB0963
Stimulation of Calpain Activity, Facilitation of Talin Degradation and Shedding of PMPs Exist as the Modalities of Prion-mediated Pathological Effects in Human Platelets
-
Abstract Number: PB0404
Strength and Deformability of Fibrin Clots: Biomechanics, Thermodynamics, and Mechanisms of Rupture
-
Abstract Number: LPB0113
Streptococcal Surface Enolase (SEN) Is Overshadowed by Plasminogen-binding Group A Streptococcal M-protein (PAM) for Human Plasminogen Acquisition and Activation
-
Abstract Number: PB0994
Stripping a Platelet “Sugar Coat” by Shear: Shear-mediated Platelet Desialylation Promotes Reduction in Platelet Count and Increased Microvesiculation
-
Abstract Number: PB1018
Structural Characterisation of GPVI in Complex with Nanobody 2 Generates a Domain-swapped GPVI Dimer: Could this Represent a Biologically Active Conformation?
-
Abstract Number: OC 09.4
Structure of the von Willebrand Factor C6 Domain and Effect of Variant p.Gly2705Arg
-
Abstract Number: PB0879
Structure-based Design of Cyclic Glycoprotein Ibα-derived Peptides Affecting Platelet Interaction with von Willebrand Factor under Shear Conditions
-
Abstract Number: OC 59.4
Studies of LMAN1 and MCFD2 Deficient Cell Lines Provide New Insight into Intracellular Trafficking of FV and FVIII
-
Abstract Number: PB1017
Study of the Affinity of Thrombin towards its Receptors on Platelets
-
Abstract Number: OC 54.4
Studying Factor XII Structure-function Relationships Using Factor XII-HGFA Chimeric Proteins
-
Abstract Number: PB1173
Subacute Mesenteric Venous Thrombosis Secondary to COVID-19: A Late Thrombotic Complication in a Non-severe Patient
-
Abstract Number: PB0430
Subcasular Hepatic Hematoma as Thrombolysis Complication. Case Report
-
Abstract Number: PB0699
Subcutaneous Marzeptacog Alfa (Activated) is Effective Treatment of Bleeding in FVII Deficient Rats
-
Abstract Number: PB1233
Success of Online CME at Improving Knowledge and Confidence around Guideline-directed Management of Cancer-associated Thrombosis
-
Abstract Number: PB0670
Success of Online CME at Improving Knowledge, Competence, and Confidence around Guideline-directed Management of Oral Anticoagulant-related Urgent Bleeding
-
Abstract Number: PB0687
Successful Experience of Emicizumab Prophylaxis in a Child with Severe Hemophilia A and Inhibitor without Previous Immune Tolerance Induction
-
Abstract Number: PO141
Successful Immune Tolerance Induction with High Dose Simoctocog Alfa in Hemophilia A Adult Patient with High Responder Inhibitor: A Case Report
-
Abstract Number: PO190
Successful Infertility Treatment and Pregnancy Outcome in a Woman with Severe Treatment-refractory ITP
-
Abstract Number: PB0725
Successful Pregnancy in a Patient with Factor XIII Deficiency and Recurrent Miscarriages
-
Abstract Number: PB0714
Successful Prophylactic Use of Coagulation Factor X in an Infant Patient in the Home Environment
-
Abstract Number: PB0864
Successful Treatment with Edoxaban in Heparin-induced Thrombocytopenia with Thrombosis: A Case Report
-
Abstract Number: PB1065
Successfully Treated Pediatric Catastrophic Antiphospholipid Syndrome with Combination of Thrombolytic Agent, Rituximab and Sirolimus
-
Abstract Number: OC 03.3
Suppression of Fibrinolysis and Hypercoagulability Link Lung Injury and Mortality in Severe COVID-19
-
Abstract Number: PB0093
Surveillance of Anticoagulation in Patients with Extracorporal Oxygenation Membrane (ECMO)
-
Abstract Number: PB0228
Suspicion of Heparin-induced Thrombocytopenia in COVID-19: Results from a Multi-centric Retrospective Study
-
Abstract Number: PB0823
Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia: A Multicenter Study of U.S. ITP Referral Centers
-
Abstract Number: PB1070
Switching of Oral Anticoagulants in People with Atrial Fibrillation: Insight from Australian General Practices
-
Abstract Number: PB1258
Symptomatic versus Incidentally Noted Isolated Subsegmental Pulmonary Embolus Outcomes
-
Abstract Number: PB0059
Synthesis and Binding Study of Two Small Heterocyclic Compounds with factor Xa Inhibitory Activity
-
Abstract Number: LPB0027
Systematic Review on Neonatal Portal Vein Thrombosis
-
Abstract Number: LPB0009
Systematic Screening for Pulmonary Embolism in Patients with Suspected Covid-19 in the Emergency Department: A Prospective Cohort Study
-
Abstract Number: PO163
Systemic Lupus Erythematosus-induced Coagulopathy: A Case Report
-
Abstract Number: PB0218
Systemic Platelet Exhaustion in Critically-ill Covid-19 Patients
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.